Skip to main content

Capped F10 for Next Generation Fluoropyrimidine Therapy of Colon Cancer

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Award date: 
Jun 7, 2016
Award amount: 
$100,000
Organization name: 
Wake Forest University Health Sciences
Principal Investigator: 
Gmeiner, William H.
Grant program category: 
Research and Equipment Support
Grant program name: 
Biotechnology Innovation Grant
Region: 
Piedmont

This project supports the commercialization of a new type of chemotherapy drug for the treatment of colon cancer, a leading cause of cancer-related death in North Carolina. Studies in animal models will test superiority relative to current therapy, and a clinical development plan will be initiated.

Fiscal year: 
2016